Our Pricing

Buy Mounjaro Weight Loss Injections Northern Ireland

Published on: June 03, 2026

When you buy Mounjaro weight loss injections Northern Ireland through Cured Pharmacy, you access the UK's most advanced weight management treatment with full clinical support from our GPhC-registered team. Mounjaro (tirzepatide) is now available to Northern Ireland patients from £124.99 with free online consultation, discreet delivery, and ongoing prescriber support throughout your treatment journey.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, creating a more comprehensive metabolic response that regulates appetite, slows gastric emptying, and improves insulin sensitivity.

In the landmark SURPASS-2 trial, participants taking the 15mg dose achieved an average body weight reduction of 22.5% over 72 weeks—substantially higher than comparator treatments [1]. The dual-receptor mechanism appears to produce superior weight loss outcomes whilst maintaining favourable safety profiles across diverse patient populations, including those with comorbid conditions such as type 2 diabetes and hypertension.

Clinical Evidence from SURPASS Trials

The SURPASS clinical programme evaluated tirzepatide across multiple trials involving over 6,000 participants worldwide [2]. Results consistently demonstrated dose-dependent weight reduction, with the majority of participants achieving clinically significant weight loss (defined as ≥5% body weight) within 12-16 weeks of treatment initiation. Importantly, weight loss was sustained throughout the 72-week study period, with minimal plateau effect observed in long-term follow-up data.

Mounjaro Availability and Delivery in Northern Ireland

Northern Ireland residents can access Mounjaro through Cured Pharmacy's fully regulated online service, which operates under the same GPhC standards that govern all UK pharmacy practice. Following a clinical assessment by one of our UK-registered prescribers, your medication is dispensed from our licensed pharmacy facility and delivered discreetly to your Northern Ireland address via secure courier service.

Delivery typically arrives within 2-3 working days across all Northern Ireland postcodes, including Belfast, Derry, Lisburn, Newry, and rural areas. All packages use 100% discreet packaging with no external pharmacy branding, ensuring complete privacy. Temperature-controlled packaging maintains the cold-chain integrity required for injectable medications during transit.

Starting Mounjaro: Dosing and Treatment Protocol

Mounjaro treatment follows a structured dose-escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [3]. All patients begin with the 2.5mg weekly dose for four weeks, which serves as an initiation period rather than a therapeutic dose. Your prescriber then increases the dose to 5mg weekly, with further escalations to 7.5mg, 10mg, 12.5mg, or 15mg based on your individual response and tolerability.

The KwikPen injection device contains four pre-filled doses and requires no manual preparation—simply attach a new needle, dial your prescribed dose, and inject subcutaneously into your abdomen, thigh, or upper arm. Most patients find the injection process straightforward after the first administration, and our clinical team provides comprehensive injection technique guidance during your consultation.

What to Expect During Treatment

During the first 4-8 weeks, you may experience mild nausea, reduced appetite, or occasional digestive changes as your body adjusts to tirzepatide [3]. These effects typically diminish with continued use and can be managed through dietary modifications such as smaller, more frequent meals and avoiding high-fat foods. Most patients report noticeable appetite suppression within the first two weeks, with measurable weight loss becoming evident by week 4-6 of treatment.

Mounjaro Pricing and Transparent Costs

At Cured Pharmacy, Mounjaro is available from £124.99 with completely transparent pricing displayed before you begin your consultation. Unlike some services that reveal costs only after assessment, we believe Northern Ireland patients deserve upfront clarity about treatment expenses. Your final cost depends on the dose prescribed by your UK clinician following their assessment of your medical history, current weight, and treatment goals.

The price includes your medication supply, clinical consultation with a UK prescriber, ongoing prescription management, and discreet delivery to your Northern Ireland address. There are no hidden fees, membership charges, or subscription requirements. Patients requiring long-term treatment can benefit from our repeat prescription service, which streamlines reordering and ensures continuous treatment without interruption.

Who Can Use Mounjaro Weight Loss Injections

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [4]. Your prescriber will calculate your BMI during the online consultation and assess whether Mounjaro represents an appropriate treatment option based on your individual circumstances.

The medication is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy or planned pregnancy, breastfeeding, and severe gastrointestinal disease [4]. Your UK prescriber will review your complete medical history, current medications, and any pre-existing conditions to determine suitability and identify potential drug interactions before issuing a prescription.

Medical Conditions Requiring Special Consideration

Patients with diabetic retinopathy, chronic kidney disease, or history of pancreatitis require additional clinical evaluation before starting tirzepatide therapy. Your prescriber may request recent blood test results or contact your GP to obtain relevant medical information if needed. This collaborative approach ensures safe prescribing and appropriate ongoing monitoring throughout your treatment course.

Alternative Weight Loss Treatments Available

Whilst Mounjaro represents the most advanced weight loss treatment currently available, Cured Pharmacy offers a comprehensive range of MHRA-licensed alternatives to suit different clinical needs and budgets. Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that demonstrated average weight loss of 14.9% in the STEP-1 trial, making it highly effective for many patients [5]. Saxenda (liraglutide) offers a daily injection option for those who prefer more frequent, lower-volume dosing.

For patients seeking non-injectable options, we provide Orlistat capsules, which work by blocking approximately 30% of dietary fat absorption in the digestive system [6]. Xenical contains the same active ingredient at prescription strength, whilst Alli and Orlos offer lower-dose formulations. Your prescriber will discuss all suitable options during your consultation, ensuring you receive the treatment most aligned with your medical profile, lifestyle preferences, and weight loss objectives.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/ [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [ID6446]. NICE Technology Appraisal Guidance. Retrieved from https://www.nice.org.uk/ [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.